Evotec: JPMorgan Chase trims voting rights to 5.54% from 5.56%
JPMorgan Chase cut its total stake in Evotec to 5.54% from 5.56%. Equity voting rights rose to 3.76% from 3.46% and voting rights via instruments fell to 1.77% from 2.09%. The threshold was crossed on Sept. 23, 2026.